Hamlet Pharma, soon to be Hamlet BioPharma, the innovative pharmaceutical company with several projects in Phase II trials in infection and cancer and an extensive…
Read More
Financial news
Hamlet Pharma AB (publ) (”Hamlet Pharma” eller “Bolaget”) meddelar idag utfallet från nyttjandet av teckningsoptionerna av serie TO 4 B, vilka emitterades under 2021. Totalt…
Opening remarks During the third quarter of the fiscal year, Hamlet Pharma has continued its clinical trial program for Alpha1H, a drug candidate in the…